Nuair a bhaineann ailse ae príomhúil le ascites, buíochán, metastasis i bhfad i gcéin, etc., tugtar ailse ae bunscoile chun cinn air. Tá sé deacair ailse ae bunscoile chun cinn a chóireáil, agus níl an éifeacht cóireála cliniciúil idéalach. Ní rogha í an mháinliacht chun ailse chun cinn ae a chóireáil toisc go bhfuil sé scaipthe chuig nóid limfe nó chuig orgáin eile.
If the liver is in good condition (Child-Pugh grade A or B), the doctor will consider treatment with the targeted therapeutic drugs Sorafenib (Nexavar) or Lenvama (Lenvima). Growth can prolong the survival time of patients. If the patient develops drug resistance, the targeted drug repaglinide (Stivarga) or the immunotherapy drug nivolumab (Opdivo) can be used instead.
In addition, keeping an eye on clinical trial information at any time and actively participating in relevant clinical trials such as chemotherapy, radiotherapy, and immunotherapy may also bring opportunities and hope for patients with advanced ailse ae. It is hoped that in the next few years, researchers will make a huge breakthrough in the field of liver cancer diagnosis and treatment.
